Medtronic Investor Handout February 2024

Medtronic's February 2024 investor handout outlines the company's strategic priorities including leading positions in secular growth markets and innovative product launches across diabetes, atrial fibrillation, cardiac rhythm management, and other segments. The presentation emphasizes comprehensive transformation, operational streamlining, mid-single digit organic revenue growth targets, and commitment to restoring earnings power while maintaining shareholder returns.